267 related articles for article (PubMed ID: 24629496)
1. Dermatological exposure to coal tar and bladder cancer risk: a case-control study.
Roelofzen JHJ; Aben KKH; Van de Kerkhof PCM; Van der Valk PGM; Kiemeney LALM
Urol Oncol; 2015 Jan; 33(1):20.e19-20.e22. PubMed ID: 24629496
[TBL] [Abstract][Full Text] [Related]
2. No increased risk of cancer after coal tar treatment in patients with psoriasis or eczema.
Roelofzen JH; Aben KK; Oldenhof UT; Coenraads PJ; Alkemade HA; van de Kerkhof PC; van der Valk PG; Kiemeney LA
J Invest Dermatol; 2010 Apr; 130(4):953-61. PubMed ID: 20016499
[TBL] [Abstract][Full Text] [Related]
3. Coal tar in dermatology.
Roelofzen JH; Aben KK; van der Valk PG; van Houtum JL; van de Kerkhof PC; Kiemeney LA
J Dermatolog Treat; 2007; 18(6):329-34. PubMed ID: 17852640
[TBL] [Abstract][Full Text] [Related]
4. Influence of dermal exposure to ultraviolet radiation and coal tar (polycyclic aromatic hydrocarbons) on the skin aging process.
Borska L; Andrys C; Krejsek J; Palicka V; Vorisek V; Hamakova K; Kremlacek J; Borsky P; Fiala Z
J Dermatol Sci; 2016 Mar; 81(3):192-202. PubMed ID: 26748978
[TBL] [Abstract][Full Text] [Related]
5. Highly increased urinary 1-hydroxypyrene excretion rate in patients with atopic dermatitis treated with topical coal tar.
Veenhuis RT; van Horssen J; Bos RP; Anzion RB; Van Der Valk PG
Arch Dermatol Res; 2002 Jul; 294(4):168-71. PubMed ID: 12111346
[TBL] [Abstract][Full Text] [Related]
6. DNA adducts in skin biopsies and 1-hydroxypyrene in urine of psoriasis patients and healthy volunteers following treatment with coal tar.
Roelofzen JH; van der Valk PG; Godschalk R; Dettbarn G; Seidel A; Golsteijn L; Anzion R; Aben KK; van Schooten FJ; Kiemeney LA; Scheepers PT
Toxicol Lett; 2012 Aug; 213(1):39-44. PubMed ID: 21810456
[TBL] [Abstract][Full Text] [Related]
7. Treatment policy for psoriasis and eczema: a survey among dermatologists in the Netherlands and Belgian Flanders.
Roelofzen JH; Aben KK; Khawar AJ; Van de Kerkhof PC; Kiemeney LA; Van Der Valk PG
Eur J Dermatol; 2007; 17(5):416-21. PubMed ID: 17673386
[TBL] [Abstract][Full Text] [Related]
8. Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study.
Pittelkow MR; Perry HO; Muller SA; Maughan WZ; O'Brien PC
Arch Dermatol; 1981 Aug; 117(8):465-8. PubMed ID: 7259240
[TBL] [Abstract][Full Text] [Related]
9. Coal tar, pine tar and sulfonated shale oil preparations: comparative activity, efficacy and safety.
Schmid MH; Korting HC
Dermatology; 1996; 193(1):1-5. PubMed ID: 8864609
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of topical calcipotriol versus coal tar and salicylic acid ointment in chronic plaque psoriasis.
Singh P; Gupta S; Abidi A; Krishna A
J Drugs Dermatol; 2013 Aug; 12(8):868-73. PubMed ID: 23986159
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal study of excretion of metabolites of polycyclic aromatic hydrocarbons in urine from two psoriatic patients.
Hansen AM; Poulsen OM; Menné T
Acta Derm Venereol; 1993 Jun; 73(3):188-90. PubMed ID: 8105615
[TBL] [Abstract][Full Text] [Related]
12. Aromatic DNA adducts in human white blood cells and skin after dermal application of coal tar.
Godschalk RW; Ostertag JU; Moonen EJ; Neumann HA; Kleinjans JC; van Schooten FJ
Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):767-73. PubMed ID: 9752984
[TBL] [Abstract][Full Text] [Related]
13. Final safety assessment of Coal Tar as used in cosmetics.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2008; 27 Suppl 2():1-24. PubMed ID: 18830861
[TBL] [Abstract][Full Text] [Related]
14. Coal tar therapy. Is it carcinogenic?
van Schooten FJ; Godschalk R
Drug Saf; 1996 Dec; 15(6):374-7. PubMed ID: 8968692
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of polycyclic aromatic hydrocarbons, 1-hydroxypyrene, and mutagenicity in urine of coal tar-treated psoriasis patients and untreated volunteers.
Santella RM; Nunes MG; Blaskovic R; Perera FP; Tang D; Beachman A; Lin JH; DeLeo VA
Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):137-40. PubMed ID: 8049634
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal alterations in peripheral blood lymphocytes, urinary mutagenicity and excretion of polycyclic aromatic hydrocarbons in six psoriatic patients undergoing coal tar therapy.
Sarto F; Zordan M; Tomanin R; Mazzotti D; Canova A; Cardin EL; Bezze G; Levis AG
Carcinogenesis; 1989 Feb; 10(2):329-34. PubMed ID: 2643486
[TBL] [Abstract][Full Text] [Related]
17. Mutagenic activity and polycyclic aromatic hydrocarbon levels in urine of humans exposed to therapeutical coal tar.
Clonfero E; Zordan M; Cottica D; Venier P; Pozzoli L; Cardin EL; Sarto F; Levis AG
Carcinogenesis; 1986 May; 7(5):819-23. PubMed ID: 3698208
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the presence of amino and nitro polycyclic aromatic hydrocarbons in a Söderberg primary aluminum smelter.
Farant JP; Ogilvie D
AIHA J (Fairfax, Va); 2002; 63(6):721-5. PubMed ID: 12570080
[TBL] [Abstract][Full Text] [Related]
19. Is dermatologic usage of coal tar carcinogenic? A review of the literature.
Pion IA; Koenig KL; Lim HW
Dermatol Surg; 1995 Mar; 21(3):227-31. PubMed ID: 7712091
[TBL] [Abstract][Full Text] [Related]
20. Review of the mechanism of action of coal tar in psoriasis.
Sekhon S; Jeon C; Nakamura M; Afifi L; Yan D; Wu JJ; Liao W; Bhutani T
J Dermatolog Treat; 2018 May; 29(3):230-232. PubMed ID: 28814117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]